McKesson Corp (MCK) Price

McKesson EPS Jumps 39% on Specialty Drug Strength

McKesson Corporation reported a 39% year-over-year increase in fiscal second-quarter adjusted earnings per share to $9.86, driven by strong growth in its specialty pharmaceutical business.